Dopexamine
Top View
- Drug-Induced Diseases
- 2020 Equine Prohibited Substances List
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- RAG Classification List *Please Note This List Does Not Include Exhaustive Information About Formulation
- 2019 Equine Prohibited Substances List
- Australasian Anaesthesia 2019
- 01 Stockleys Pocket Companion 2013 1..542
- FEI Prohibited Substances List the 2011 List of FEI Prohibited Substances Will Come Into Effect on 4 April 2011
- (12) United States Patent (10) Patent No.: US 9,050,293 B2 Cohen Et Al
- Wo 2007/044693 A2
- Human Neurogenesis Assay: MKC-231 + AMPA
- Human Neurogenesis Assay: Ramelteon
- Dopexamine, a New Dopaminergic Receptor Agonist, in Patients with Chronic Heart Failure
- Dopexamine Has No Additional Benefit in High-Risk Patients
- Harmonized Tariff Schedule of the United States (2006) (Rev
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Inotropes, Vasopressors and Vasodilators Anand Kumar, MD
- Pharmaceutical Appendix to the Harmonized Tariff Schedule